Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system
- PMID: 22448649
- DOI: 10.1111/j.1464-410X.2012.11013.x
Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system
Abstract
Objective: To examine the frequency of PSA testing in men aged ≥75 years before and after the 2008 US Preventive Services Task Force (USPSTF) recommendation to stop prostate-specific antigen (PSA) screening at age 75.
Materials and methods: Data were obtained from the Behavioral Risk Factor Surveillance System (BRFSS) surveys completed in 2006, 2008 and 2010. Men aged ≥ 76 years at the time of survey and without a prostate cancer diagnosis were included in the study. The percentage of men who had a PSA test in the year before the survey was computed separately for survey years 2006, 2008 and 2010.
Results: The estimated percentages of men with a PSA test in the year before the survey were 60% (95% CI: 58-62%), based on 9033 respondents interviewed in 2006, 63% (95% CI: 62-65%), based on 12,063 respondents interviewed in 2008, and 60% (95% CI: 59-61%), based on 14,782 respondents interviewed in 2010.
Conclusion: No substantial reduction in the frequency of PSA testing was observed in the BRFSS 2010 survey data compared with the earlier years, suggesting that the USPSTF 2008 recommendation had no major impact on the frequency of PSA testing in older men in the USA.
© 2012 BJU INTERNATIONAL.
Similar articles
-
Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2. Urol Oncol. 2014. PMID: 23911680
-
Behavioral associations between prostate and colon cancer screening.J Am Coll Surg. 2005 Feb;200(2):216-23. doi: 10.1016/j.jamcollsurg.2004.10.015. J Am Coll Surg. 2005. PMID: 15664097
-
Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.Am J Prev Med. 2013 Aug;45(2):182-9. doi: 10.1016/j.amepre.2013.04.005. Am J Prev Med. 2013. PMID: 23867025
-
Screening for prostate cancer: the current evidence and guidelines controversy.Can J Urol. 2011 Oct;18(5):5875-83. Can J Urol. 2011. PMID: 22018148 Review.
-
Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.Int J Urol. 2009 May;16(5):458-64. doi: 10.1111/j.1442-2042.2009.02293.x. Epub 2009 Apr 1. Int J Urol. 2009. PMID: 19341365 Review.
Cited by
-
Nonlinear Relationship Between Age and Likelihood of Undergoing Prostate-Specific Antigen Testing, and the Predictive Factors of Testing at Different Ages.Am J Mens Health. 2021 May-Jun;15(3):15579883211026515. doi: 10.1177/15579883211026515. Am J Mens Health. 2021. PMID: 34167355 Free PMC article.
-
Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.Cancer Rep (Hoboken). 2021 Aug;4(4):e1352. doi: 10.1002/cnr2.1352. Epub 2021 May 1. Cancer Rep (Hoboken). 2021. PMID: 33932150 Free PMC article.
-
Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.Cancer Causes Control. 2020 Sep;31(9):861-867. doi: 10.1007/s10552-020-01324-x. Epub 2020 Jun 17. Cancer Causes Control. 2020. PMID: 32556947 Free PMC article.
-
Conceptual review of key themes in treating prostate cancer in older adults.J Geriatr Oncol. 2020 Jun;11(5):893-898. doi: 10.1016/j.jgo.2019.10.005. Epub 2019 Nov 5. J Geriatr Oncol. 2020. PMID: 31704035 Free PMC article. Review. No abstract available.
-
A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?Int Braz J Urol. 2019 May-Jun;45(3):478-485. doi: 10.1590/S1677-5538.IBJU.2018.0179. Int Braz J Urol. 2019. PMID: 31038862 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
